Align Technology EBIT Margin
The EBIT Margin (Operating Margin) of Align Technology (ALGN) as of Jul 20, 2026 is 14.51 %. In the previous year, EBIT Margin (Operating Margin) was 16.80 % — a change of -13.68% (lower).
Get this data via API
Financial Data API
EBIT Margin
14.51 %
YoY
-13.68%
Last updated:
EBIT Margin (Operating Margin) of Align Technology is 2026 14.51 % . EBIT Margin (Operating Margin) of Align Technology was 2025 16.80 % . It decreases by -13.68% lower compared to the previous year.
For Align Technology, the operating (EBIT) margin of 14.5% is down versus 24.7% a few years ago.
Access this data via the Eulerpool API
Align Technology Stock analysis
What does Align Technology do? Align Technology was founded in California in 1997 and specializes in the development and manufacturing of transparent aligners. The company aims to make orthodontic correction easier and improve results by offering innovative, patient-friendly technologies and treatment options.
The business model of Align Technology is based on the development, manufacturing, and marketing of clear aligners, sold under the brand name Invisalign. These transparent aligners are an alternative to traditional orthodontic treatment with fixed braces. The Invisalign aligners are made from a transparent material that is nearly invisible, resulting in a more aesthetic appearance. They are customized for each patient and do not require adjustments like traditional braces. Instead, the patient is given new, slightly adjusted aligners every few weeks to enable gentle and pain-free movement of the teeth.
While initially focusing on the development and marketing of clear aligners, Align Technology has expanded its product range in recent years to include digital treatment planning and intraoral scanners. Digital treatment planning is a computer program that diagnoses orthodontic problems and creates treatment plans. The intraoral scanner is a device inserted into the mouth to create three-dimensional models of teeth and jaws. Both products facilitate the planning and implementation of orthodontic treatments and improve the accuracy of diagnosis.
Align Technology has become a leading provider of orthodontic technologies and treatment products in recent years. The company operates globally, with its products being distributed in over 100 countries. Align Technology also operates several research centers and labs worldwide to promote the development of new technologies and products.
Align Technology has received several significant awards in the past, including the Frost & Sullivan Product Leadership Award for the Orthodontic Clear Aligner Market and the Red Dot Design Award for the design of the Invisalign software. These awards highlight the company's commitment to innovative technologies and the highest quality.
Overall, Align Technology has revolutionized the way orthodontic corrections are performed. With its focus on patient-friendly design and innovative technology, Align Technology has helped improve the treatment process and make the beauty ideal of a radiant smile more accessible to all. Align Technology is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Align Technology stock
EBIT Margin (Operating Margin) of Align Technology is 14.51 % in 2026.
Access this data via the Eulerpool API
Margins — Align Technology
All Key Metrics — Align Technology
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth